» Articles » PMID: 19717093

30 Years and a Long Way into P53 Research

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2009 Sep 1
PMID 19717093
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Among the 278,092 publications indexed into PubMed in 1979, a handful of articles stand out as the foundation of one of the most profound forays into the molecular basis of carcinogenesis: the discovery of the p53 tumour-suppressor protein. In the 30 years since then, understanding of p53 has progressed from obscure oncogene to key tumour-suppressor gene with clinical potential. Yet, p53 research has not followed a straight course. In this Historical Review, we describe how the 1979 discovery has shaped our view of the molecular basis of cancer, and identify some crucial steps ahead to transfer the wealth of knowledge accumulated on p53 into applications to cancer prevention and treatment.

Citing Articles

Understanding the complexity of p53 in a new era of tumor suppression.

Liu Y, Su Z, Tavana O, Gu W Cancer Cell. 2024; 42(6):946-967.

PMID: 38729160 PMC: 11190820. DOI: 10.1016/j.ccell.2024.04.009.


Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children.

Skhoun H, Khattab M, Belkhayat A, Chebihi Z, Bakri Y, Dakka N Mol Biol Rep. 2022; 49(9):8291-8300.

PMID: 35705773 DOI: 10.1007/s11033-022-07643-3.


A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.

Li H, Zhang W, Zhao K, Zhao D, Zheng S, Hu Y J Biol Chem. 2020; 295(12):4049-4063.

PMID: 32005663 PMC: 7086043. DOI: 10.1074/jbc.RA119.011411.


TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.

Mohammed Basabaeen A, Abdelgader E, Ahmed Babekir E, Abdelrahim S, Eltayeb N, Altayeb O Asian Pac J Cancer Prev. 2019; 20(5):1579-1585.

PMID: 31128065 PMC: 6857868. DOI: 10.31557/APJCP.2019.20.5.1579.


Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.

Huang C, Wu S, Ji H, Yan X, Xie Y, Murai S Sci Adv. 2017; 3(10):e1701383.

PMID: 29057323 PMC: 5647124. DOI: 10.1126/sciadv.1701383.